Introduction
The origin of cancer in the humans is considered to be a complex and multistep process. In all cases, however, the cancer cell contains a genome in which gene(s) are either altered or wrongly expressed. Therefore, alterations in DNA have been thought to be a crucial first step (initiation) in the long chain of events leading to cancer.
The occurrence of DNA lesions in cells in the human body is not a rare phenomenon. They can occur due to exposure to many exogenous agents present in our food, environment, and occupational situations. A major additional cause of DNA damage in cells is the action of endogenous factors like the intermediates of metabolic and detoxifying processes in our body (1) . In toto the human body contains about 1014 cells; endogenous factors alone may induce around 4000 DNA lesions/day/cell, i.e., 4 x 1017 DNA lesions/body/day. Since the frequency of the transformation of cells into cancerous ones in the body is orders of magnitude lower than that of the formation of DNA lesions, it is obvious that only a limited number of DNA lesions are related to the process of neoplastic transformation. Some of the DNA lesions in cells may be converted to DNA sequence alterations (i.e., mutations), but still the number of DNA alterations is considerably greater than the number of cells that are ultimately converted into cancer cells. A partial explanation is that the majority of DNA lesions induced by exposure of mammalian cells to genotoxic agents, like X-rays, are more lethal than mutagenic, although other agents such as the alkylating agent ethyl methane sulfonate cause DNA lesions which, at equal level of survival, are considerably more mutagenic in the same kind of mammalian cells than X-ray-induced DNA lesions (2) . Furthermore, when DNA lesions form mutations, these are not necessarily those that lead to cancer.
Another explanation for the difference in the mutagenic potency of genotoxic agents is variability in the fidelity with which individual DNA lesions in cells are repaired. The vital role of DNA repair in the etiology of cancer was first established by Cleaver (3) , who found that cells 4rom patients with the hereditary, cancer-prone disease xeroderma pigmentosum (XP) had defective repair of ultraviolet radiation (UV)-induced DNA damage. XP is an autosomal recessive disorder occurring at a frequency of about 1-10 per 106 individuals. Patients suffering from this disease have a greater chance of developing neoplasia on parts of the body that are exposed to solar radiation. In several other genetic diseases there is increased susceptibility to DNA damaging agents; these include ataxia telangiectasia, Fanconi's anemia, Bloom's syndrome, Cockayne's syndrome, and trichothiodystrophy. The first three diseases are also associated with an increased incidence of cancer, but the other two are notably not. On the basis of these observations it can be hypothesized that either a) not all DNA lesions lead to neoplastic transformation or b) the existence of high-fidelity DNA repair processes is an essential prerequisite for preventing tumor Over the past 20 years, the genotoxic activity of chemicals has been assessed typically by conducting a series of short-term tests using various organisms. Most of these tests were designed to be rapid and comparatively inexpensive; some were proposed as surrogates for rodent carcinogenicity or rodent germ-cell bioassays. It is clear, however, that the end points and target cells used in shortterm assays are dissimilar to the phenomena of carcinogenesis and germ-cell mutation. The notion that the universe of chemicals is dichotomous toward the carcinogenic/mutagenic potential of individual chemicals has been the led to the development of tier or battery approaches for determining genotoxic properties in short-term assays. A weight-of-evidence approach to the analysis of a large database of short-term test results showed an almost total absence of results indicating a division of the chemical universe into mutagenic and nonmutagenic chemicals (4) (5) (6) . Rather, genotoxicity appears to be a consistent property throughout this universe. The genotoxicity of a chemical can be expressed in terms of a so-called genotoxic The agent scores of the chemicals listed in Table 1 are numbered and shown with the standard deviation; other agent scores ( +) are those of genotoxic agents described by Lohman et al. (4 agent score, and a wide variety of chemicals can be ranked in this way, using the results of short-term test with a minimal number of end points in vitro and in vivo. This approach is demonstrated in Figure 1 ranking of the genotoxic potential of halogenated air pollutants is possible; however, whether this genotoxic potential also reflects the carcinogenic potential of a chemical needs further evaluation.
Structure-Activity Relationships
Not only short-term tests but also the physicochemical properties of a chemical have been used to predict its relative genotoxic potential. This approach has been especially successful for a range of simple monofunctional alkylating agents, such as N-ethyl-N-nitrosourea, ethylene oxide, and 2,2-dichlorovinyldimethyl-phosphate. The way in which these compounds react with DNA can be described by their nucleophilic selectivity, as expressed by the Swain-Scott s value. As first described by Barbin and Bartsch (7) , a relationship exists between the s value and the carcinogenic potency of monoalkylating chemicals in rodtnts (median TD50 estimates). That study was extended by Vogel et al. (8) , and a limited summary of the data obtainied by those investigators is presented in Figure   2 . For the monofunctional alkylating agents studied, the relationship depicted in Figure 2 holds not only for nucleophilic selectivity but also for the initial N7-alkylguanine/06-alklyguanine ratio in DNA. Those observations indicate that the modifications at base oxygens in DNA by monoalkylating agents are key DNA lesions for determining their carcinogenic potency in rodents (8) .
The relationship shown in Figure 2 was not found when polyfunctional alkylating agents were studied. Polyfunctional alkylating agents possess more than one active ligand that can react with nucleophilic centers in DNA. These agents, including a considerable number of antitumor drugs such as cisplatin and cyclophosphamide, can cross-link DNA strands. As Vogel et al. (8) describe, their carcinogenic potential is not directly related to their nucleophilic selectivity (see also Therefore, DNA is not the main target and these agents have low carcinogenic potency.
The cross-linking property appears to be the main determinant of the low TD50 of polyfunctional carcinogens. Interestingly, the group of cross-linking compounds can be recognized relatively easily by their high efficiency in inducing clastogenic effects in cells. The relative clastogenic efficiency of genotoxic agents can be determined in the fruit fly, Drosophila melanogaster, by measuring the ratio ofinduced ring-X loss (a chromosomal damage end point, CA) to sex-linked recessive lethal mutations (RL) (CA/RL). Compounds with a CA/RL ratio greater than about 1.2 are likely to be cross-linking agents (8) (Table 2) . Thus, this method has prognostic value for discriminating monofunctional alkylating agents from those with cross-linking properties.
Processing of DNA Damage in Human Cells
Mechanisms of DNA Repair A mammalian cell contains about 50 cm of DNA, which has to be reduced some 50,000 times in size to fit into the cell nucleus. Although not always recognized it is obvious that the processes behind DNA repair are strongly influenced by the organization ofthe nucleus in the cell. Considerable evidence is now available to suggest that regions of the chromatin that are engaged in DNA replication and transcription are in a more open configuration than the bulk ofthe chromatin. The nonrandomness ofthe functioning of DNA repair processes and, ultimo, the alteration of DNA (i.e., mutations) can be recognized at least the level of the chromatin, the individual genes, the DNA strand in genes actively involved in transcription of RNA, and at the individual type of DNA damage.
The complexity of DNA damage processing can be demonstrated in experiments in which normal human fibroblasts and fibroblasts from patients with the DNA repair-deficient syndrome XP complementation group C (XP-C) are exposed to low doses of 254 nm UV. At Loop Repair tive X-chromosomal sequence designated 754 (located in the proximity of the Duchenne's muscular dystrophy gene) in human cells. As shown in Figure 3B , CPDs are repaired more quickly in active housekeeping genes than in inactive genes or in the (bulk) total DNA of the genome. XP-C cells can efficiently repair active genes but are defective in repairing CPD in transcriptionally inactive DNA (11) .
The relationship between a specific DNA repair process and RNA transcription in active genes was further elaborated by studying the repair of CPD in the transcribed and nontranscribed DNA strand in the ada gene of normal and XP-C fibroblasts [ Figure 3C (12,13)]: XP-C cells efficiently repaired the transcribed DNA strand but were inhibited from repairing the nontranscribed DNA strand.
The fourth level at which different DNA repair processes operate in human and other mammalian cells is at the kind of lesion that is induced in DNA. Discussions have been going on for many years about which is the most significant lesion (key lesion) for mutagenesis in mammalian cells after exposure to UV. The two major types of DNA lesion induced by UV are CPD and the 6-4 pyrimidone photoproduct. Zdzienicka et al. (14) found that a revertant of the UV-sensitive Chinese hamster cell line VH1, which has similar mutation induction frequencies as wild-type cells after exposure to UV exhibits complete deficiency in dimer removal from the X-chromosomal hypoxanthine phosphoribosyl transferase (hprt) gene and a normal level of 6-4 pyrimidone photoproduct repair in the genome overall. The level of UV-induced mutations was similar to that found in normal cells, which indicates a minor role for dimers in mutagenesis; however, this may not be a general rule for all cell types from all mammalian species. The main conclusion is that different repair processes and/or different efficiency in the DNA repair process exist for different DNA lesions and that this may influence strongly which DNA damage can be considered to be the key lesion for mutation induction after exposure to a genotoxic agent. Of course, this still leaves open the ENU Induced (20.2) brain question of whether a DNA lesion for which no repair process exists within cells should be considered to be a key lesion for possible adverse biological effects.
Organ-and Tissue-Specific Carcinogenesis/Mutagenesis Thmor formation in both rodents and humans after exposure to genotoxic agents commonly occurs in specific organs and tissues. This may indicate that several groups of precarcinogens need metabolic activation and that activation differs in the various organs of the body. The organ and tissue specificity of tumor formation by many other genotoxicants, which are capable of inducing DNA lesions in all cells of the body, is still not understood.
Few methods are available to study the organ-and tissue-specific effects of DNA lesions in vivo, but transgenic mouse model systems have been proposed recently which allow study of mutations in vivo (15, 16) . One of these strains of transgenic mice harbors multiple copies of a bacteriophage A shuttle vector containing the prokaryotic lac Z gene (AgtlOLacZ vector), integrated in a head-to-tail arrangement in the genome, which provides a target for mutagenesis in all organs and tissues of the transgenic animal (17) . The integrated vectors can be rescued from total genomic DNA with high efficiency by packaging in vitro and the induction of mutations can be analyzed after propagation of the phages in a LacZ -strain of the bacterium Escherichia coli C (18) . Several strains of transgenic mice have been produced, each with a different number of shuttle vectors at a different integration site in the genome (17) .
In Figure 4 , an example is given of the induction of mutations in the brain and liver of the strain 20. appeared to be three times greater than those in liver cells from the same animal. Since in this case the vectors were isolated from postmitotic brain tissue of adult transgenic mice, DNA replication had not taken place after exposure, and the observed mutation may have been the result of an on-going error-prone DNA repair process in nondividing cells. This experiment shows that even after exposure to a directly acting agent like N-ethyl-N-nitrosourea, which induces a similar kind and similar amounts of DNA lesions in all cells of the body, there is a striking difference in mutation induction in different organs.
Of course, it must be realized that the XgtlOLacZ vector is heavily methylated in vivo and should be considered an inactive gene; no information can be given on the possible differential response of mutation induction in an active housekeeping gene. Still, this kind of experiment provides a first approach to mechanistic studies at the organ and tissue level in an individual mammal. Recently, Gossen et al. (19) provided evidence that the integration site of the vector is an important parameter in the occurrence of spontaneous mutations. They found that the background mutation frequencies in three transgenic mouse strains (20.2: 80 copies, autosomal; 40.6: 35 copies, autosomal; 35.5:15 copies, X-chromosomal) varies considerably. Especially noteworthy was the high spontaneous mutation frequency in cells of the liver (and also the brain) of strain 35.5 (Fig. 4) . These results indicate that the mutability of genes present in the genome ofmammalian cells is not uniform and, therefore, clearly indicates the presence of mutational "hot spots" in the genome of somatic cells in vivo.
A Biomonitoring Exposure to Genotoxic Agents in Human Populations
Cytogenetics It is generally recognized that chromosomal changes are associated with the process of tumor development. Although the molecular basis for the relationship between specific chromosomal changes and cancer is not well understood in all cases, cytogenetics is one of the most frequently used methods to establish human exposure to mutagens and/or carcinogens. Conventional techniques for measuring chromosomal changes require that the cells (in humans, usually stimulated peripheral blood lymphocytes) be proliferating, so that chromosomes in interphase can be seen at mitosis or as micronuclei (20) . This, however, limits application of this approach to a specific class of cells.
A method for studying chromosomal aberrations in nondividing cells has been improved and made available for screening oflarge human populations. This involves the technique of premature chromosome condensation (PCC); i.e., when mitotic cells are fused with interphase cells, the nuclei of the interphase cells undergo an immediate prophaselike reaction, such that the nuclear envelope is disassembled and the chromatin condensed into chromosomes ( classical detection of chromosomal breaks in metaphase preparations is demonstrated in Figure 6 . In this experiment, human lymphocytes were irradiated with various doses of X-rays, and chromosomal breaks were scored using the PCC method 1 hr after irradiation and as chromosomal fragments in stimulated irradiated cells 48 hr after irradiation. As can be concluded from the data shown in Figure 6 , the PCC method is about 10 times more sensitive than the classical method of scoring chromosomal fragments. The PCC technique is also useful for monitoring responses to therapeutic treatment of malignant tumors (21) . In principle, it will even be possible to study partial body irradiation due to occupational and/or accidental exposures. The cytogenetic damage in the fraction of exposed cells present among a huge number of normal cells can be detected with PCC. This was shown in a reconstruction experiment in which human lymphocytes were irradiated with X-rays (8 Gy) and mixed with a specified amount of un-irradiated cells (Table 3) . Subsequently, the human cells were fused with mitotic Chinese hamster cells, and chromosomal fragments (PCC) were scored in individual cells; thus the fraction of damaged/ undamaged cells in the mixed population can be accurately calculated. The PCC method is sensitive enough to detect the presence of only 3% unirradiated cells in a population of 97% irradiated cells (Table 3 ). This suggests that the extent of partial body irradiation in vivo could be accurately determined by the PCC method.
Molecular Dosimetry of DNA Lesions
Approaches for using DNA lesions as a basis for elucidating dose-response relationships in carcinogenexposed humans and animals have been developed through molecular dosimetry. In comparison with approaches based on external exposure, molecular dosimetry offers the distinct advantage of being capable of integrating dose-dependent differences in absorption, distribution, biotransformation, and DNA repair, allowing the determination of exposures to carcinogens more accurately and over a wide range of doses (22) . Molecular dosimetry in vivo, especially in humans, is complicated by a number of factors, the major one being that DNA lesions are formed in relatively small quantities, at an upper limit of about 100 fmole/,g DNA [< 3 DNA lesions per 105 "normal" DNA nucleotides (23) (24) (25) ]; in humans, often levels down to 3 DNA lesions per 107 "normal" nucleotides are often common.
Samples of human target tissues cannot be collected routinely, and surrogates (like DNA from nucleated blood cells) must be used. As long as there is a parallel between the level of DNA lesions in target and surrogate tissues, the latter can be used as a measure of the former. Another possible surrogate as an indicator of DNA damage may be protein damage: use of hemoglobin adducts as a dose monitor for alkylating and arylating genotoxic agents has been developed successfully by the group of Ehrenberg [(26) for further references, see Ehrenberg (27) and Neumann (28) ]. The existence of a linear relationship between the levels of DNA lesions and of the carcinogen in the environment or absorbed into the body will, of course, facilitate such a comparison. Such parallels and linear relationships have been observed in experimental animals and are indicated in man, but cannot be generalized (29) .
Two techniques-immunoassays to measure the presence of specific DNA adducts and 32P-postlabeling-have found general utility for detection of DNA lesions in both experimental animals and humans. In the immunological approach, monoclonal or polyclonal antibodies are raised against either carcinogen-modified DNA or carcinogennucleoside DNA lesions (adducts) coupled to protein carriers. The antibodies are then used to quantify specific adducts in the DNA of exposed cells. In the 32P-postlabeling method, some DNA adducts can be detected at a level approaching one adduct in about 1010 "normal" nucleotides (at least 10-100 times more sensitive than comparable immunochemical techniques). A major problem with the 32P-postlabeling method is, however, identification of the observed adducts. Adducts to hemoglobin and serum albumin are the only protein adducts so far used for molecular dosimetry in human samples. Protein Figure 7 shows an example of the spectrum of DNA alterations found in hprt T-cell mutants isolated from the blood of normal, healthy people (background mutation spectrum; controls in Figure 7 ), in people occupationally exposed to high concentrations of ethylene oxide, and in smokers. Only the spectra of DNA base alterations are given; information can also be obtained on the occurrence of deletions, frameshifts, or base insertions in the hprt gene. The spectrum of DNA base alterations in the hprt gene already shows clearly that the background spectrum of DNA alterations is different from that of exposed people and that differences also occur depending on the agent. The spectrum of DNA alterations in mutant T-cells from smokers, for instance, is missing the class of GC to TA DNA base transversions, which is present in background mutations and to a lesser extent in mutated cells from people exposed to ethylene oxide (Fig. 7) . The 
